Biologic Solutions for Chronic Wounds in Bridgeport, CT

What I’d check before adding biologic solutions chronic wounds here

CDC PLACES (2023, crude) estimates 13% of adults in Bridgeport have diagnosed diabetes — 1.0 points above the U.S. 12% figure. Census city-proper population is 148,529. If you are adding biologic solutions chronic wounds, start with that epidemiology and with National Government Services (NGS) (JK) — not with a “near me” clinic listing. Hawk Medical ships nationwide; Joe Bradley’s own practice uses the same product classes.

Where Bridgeport programs actually stall

• CDC PLACES (2023, crude) estimates 13% of adults in Bridgeport have diagnosed diabetes — 1.0 points above the U.S. 12% figure. Adult obesity in Bridgeport is 33.5% (CDC PLACES 2023). That shows up in wound offloading and in joint-preservation volume — not as a slogan. A CTP without offloading and serial measurements still fails JK review. Product is the last step, not the first.
• First Coast (Florida) is the only single-state MAC; every other state shares a contractor with neighbors. Connecticut is JK — copy-pasting a Florida LCD packet here is a denial pattern we still see.
• Medicare wound-care biologics in Connecticut are paid under National Government Services (NGS) (JK). CTP and skin-substitute LCDs are MAC-specific — a protocol that billed cleanly in another jurisdiction can stall here if documentation does not match JK coverage articles.

Uninsured mix and Medicare CTPs in the same building

JK reviewers still want serial wound measurements and conservative-care history before CTPs, whether diabetes in Bridgeport is 13% or not. PLACES is planning data. The LCD is the claim.

How we’d stand this up in clinic